Symptom prevalence, intensity, and distress in patients with inoperable lung cancer in relation to time of death

被引:101
作者
Tishelman, Carol
Petersson, Lena-Marie
Degner, Lesley F.
Sprangers, Mirjam A. G.
机构
[1] Stockholm Sjukhem Fdn, Res & Dev Unit, S-11235 Stockholm, Sweden
[2] Karolinska Inst, Dept Neurobiol Care Sci & Soc, S-10401 Stockholm, Sweden
[3] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England
[5] Univ Manitoba, Helen Glass Ctr Nursing, Fac Nursing, Winnipeg, MB, Canada
关键词
D O I
10.1200/JCO.2006.08.7874
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose To examine symptom prevalence, intensity, and association with distress in patients with inoperable lung cancer (LC), using time to death as point of reference. Patients and Methods A consecutive sample of 400 patients completed the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30 plus a 13-item LC-specific scale and the Thurstone Scale of Symptom Distress-Lung Cancer at six time points during the first year after diagnosis. Patients were divided into subgroups, using data from the time point closest to death (< 1; 1 to 2; > 2 to 3; > 3 to 6; > 6 to 12; and > 12 months before death) for analysis. Results More than 50% of patients in all subgroups reported problems related to physical, role, and emotional functioning; fatigue; dyspnea; and cough. In general, functional levels were lower and symptoms higher in subgroups closer to death. Notably, clinically relevant differences were also found in role and social functioning and appetite loss between the two groups furthest from death. A consistent pattern was found among the six subgroups, with breathing, pain, and fatigue rated as the symptoms most associated with distress. Conclusion High prevalence of symptoms was found in all subgroups, with higher intensity in subgroups closer to death, indicating a need for prophylactic and proactive symptom management. Less concordance was found among symptom prevalence, intensity, and association with distress in subgroups further from death. Future studies should investigate longitudinal associations between symptoms with low intensity and high distress, and examine their clinical implications.
引用
收藏
页码:5381 / 5389
页数:9
相关论文
共 39 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   THE EORTC QLQ-LC13 - A MODULAR SUPPLEMENT TO THE EORTC CORE QUALITY-OF-LIFE QUESTIONNAIRE (QLQ-C30) FOR USE IN LUNG-CANCER CLINICAL-TRIALS [J].
BERGMAN, B ;
AARONSON, NK ;
AHMEDZAI, S ;
KAASA, S ;
SULLIVAN, M .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (05) :635-642
[3]   Quality of life in patients with advanced non-small cell lung cancer [J].
Bozcuk, Hakan ;
Dalmis, Berna ;
Samur, Mustafa ;
Ozdogan, Mustafa ;
Artac, Mehmet ;
Savas, Burhan .
CANCER NURSING, 2006, 29 (02) :104-110
[4]   Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer [J].
Brown, J ;
Thorpe, H ;
Napp, V ;
Fairlamb, DJ ;
Gower, NH ;
Milroy, R ;
Parmar, MKB ;
Rudd, RM ;
Spiro, SG ;
Stephens, RJ ;
Waller, D ;
West, P ;
Peake, MD .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7417-7427
[5]   Symptom prevalence, distress, and change over time in adults receiving treatment for lung cancer [J].
Cooley, ME ;
Short, TH ;
Moriarty, HJ .
PSYCHO-ONCOLOGY, 2003, 12 (07) :694-708
[6]   Patterns of symptom distress in adults receiving treatment for lung cancer [J].
Cooley, ME ;
Short, TH ;
Moriarty, HJ .
JOURNAL OF PALLIATIVE CARE, 2002, 18 (03) :150-159
[7]   Symptoms in adults with lung cancer: A systematic research review [J].
Cooley, ME .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2000, 19 (02) :137-153
[8]   SYMPTOM DISTRESS IN NEWLY-DIAGNOSED AMBULATORY CANCER-PATIENTS AND AS A PREDICTOR OF SURVIVAL IN LUNG-CANCER [J].
DEGNER, LF ;
SLOAN, JA .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1995, 10 (06) :423-431
[9]  
FAYERS P, 1930, EORTC OLQ C30 SCORIN
[10]  
Fayers P, 1998, EORTC QLQ-C30 reference values